S. Pollard

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment

Simon P. Duffy, Truxton L. Jackson, Mark Lansdown et al. · Human Reproduction · 2005 · 62 citations · Full text

Medicine, Oncology, Pharmacology +11

The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data

Simon P. Duffy, Trachette L. Jackson, Mark Lansdown et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2003 · 28 citations

Medicine, Oncology, Pharmacotherapy +11